Thought JP provided clear vision going forward. was a good CC. fully expect the Tyzeka resistance vs others (in light of the all drug characteristics) will be better understood w/ education / time.
i am excited with the progress to date and look forward to 2007 and beyond for Idenix
I missed the webcast (and probably won't get to it until later this pm) but glad to hear it was brought up at all - I thought it was an excellent point you raised back when tyzeka was first approved that really was missed by some in the investment community..the MOST important thing now is to educate prescribers!